STRUCTURAL AND ELECTRONIC REQUIREMENTS FOR POTENT AGONISTS AT A NICOTINIC RECEPTOR

被引：39

作者：

SPIVAK, CE

GUND, TM

LIANG, RF

WATERS, JA

机构：

[1] UNIV MARYLAND,SCH MED,DEPT PHARMACOL & EXPTL THERAPEUT,BALTIMORE,MD 21201

[2] NIDA,ADDICT RES CTR,BALTIMORE,MD 21224

[3] NEW JERSEY INST TECHNOL,DEPT CHEM & CHEM ENGN,NEWARK,NJ 07102

[4] NIADDKD,BETHESDA,MD 20205

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1986年 / 120卷 / 01期

关键词：

D O I：

10.1016/0014-2999(86)90652-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：127 / 131

页数：5

共 9 条

[1] STRUCTURE AND ACTIVITY OF ACETYLCHOLINE [J].

BEERS, WH ;

REICH, E .

NATURE, 1970, 228 (5275) :917-&

[2]

COLQUHOUN D, 1971, LECTURES BIOSTATISTI

[3] AN ATTEMPT TO SIMULATE THE BIOGENESIS OF STRYCHNINE .2. PREPARATION AND TRANSFORMATIONS OF 3-(2-4'-PYRIDYLACETAMIDOETHYL)INDOLE [J].

KATRITZKY, AR .

JOURNAL OF THE CHEMICAL SOCIETY, 1955, :2586-2594

[4]

KHROMOVBORISOV NV, 1976, DOKL AKAD NAUK SSSR+, V230, P1250

[5]

LAMBRECHT G, 1981, ARZNEIMITTELFORSCH, V31-1, P634

[6] METHYL 1-METHYL-1,2,3,6-TETRAHYDROISONICOTINATE [J].

LYLE, RE ;

PERLOWSKI, EF ;

TROSCIANIEC, HJ ;

LYLE, GG .

JOURNAL OF ORGANIC CHEMISTRY, 1955, 20 (12) :1761-1766

[7]

Politzer P., 1981, CHEM APPL ATOMIC MOL, P1, DOI DOI 10.1007/978-1-4757-9634-6

[8]

SPIVAK CE, 1980, MOL PHARMACOL, V18, P384

[9]

SPIVAK CE, 1983, MOL PHARMACOL, V23, P337

← 1 →